Researchers discover potential
epilepsy drug using zebrafish
Epygenix Therapeutics has recruited a drug repurposing strategy, because fast forward drug development using existing drugs is suitable to rare diseases given the poor health outcomes and unmet medical need. Key advantages of this strategy are:
for each drug is already established, as we are screening drugs approved by the FDA for other indications
of failure by unexpected adverse events is dramatically reduced, as these drugs have already been evaluated
of progress is rapid, as these drugs can bypass early drug development phases.